文献速递肺栓塞与肺血管病

肺动脉楔压轨迹对肺动脉高压的意义

Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究纳入301例肺动脉高压患者,通过组基轨迹模型构建10年mPAWP轨迹,发现存在高轨迹(23.6%)和低轨迹(76.4%)两组。初始mPAWP≥12 mm Hg可预测高轨迹(OR 3.2),高轨迹与更短的无移植生存相关。

要点

  • 初始mPAWP≥12 mm Hg可预测10年mPAWP高轨迹(OR 3.2, 95%CI 1.4-6.1)。
  • 约25%的PAH患者随访中演变为第2组肺动脉高压生理。
  • mPAWP高轨迹与更短的无移植生存相关,但年龄校正后不显著。

核心结论

  • 10年内mPAWP呈现两种不同轨迹,约25%患者演变为第2组肺动脉高压生理。
  • 初始mPAWP≥12 mm Hg是mPAWP高轨迹的最强预测因子之一。

研究设计与样本

  • 多机构医疗系统回顾性队列研究,纳入301例成人PAH患者,均接受两次及以上右心导管检查。
  • 采用组基轨迹模型构建mPAWP轨迹,LASSO回归进行特征选择,逻辑回归评估关联。

主要发现

  • mPAWP高轨迹组71例(23.6%),低轨迹组230例(76.4%)。
  • 初始mPAWP中位数:高轨迹组12 mm Hg(IQR 8-14),低轨迹组9 mm Hg(IQR 6-11),P<0.001。
  • 初始mPAWP≥12 mm Hg预测高轨迹的OR为3.2(95%CI 1.4-6.1,P=0.0006)。
  • 高轨迹组中位无移植生存7.8年,低轨迹组11.3年(log-rank P=0.017),年龄校正后P=0.217。

关键数值与推荐

  • 初始mPAWP≥12 mm Hg可作为预测mPAWP高轨迹的指标(OR 3.2, 95%CI 1.4-6.1)。

临床怎么用

  • 对PAH患者,初始mPAWP≥12 mm Hg提示需关注左心疾病相关肺动脉高压的演变。
  • 常规基线数据可用于预测长期mPAWP轨迹,辅助风险分层。

局限性

  • 研究为回顾性设计,样本来自单一地区医疗系统,外推性受限。
  • 年龄校正后高轨迹与无移植生存的关联不再显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: The mean pulmonary arterial wedge pressure (mPAWP) is the critical hemodynamic factor differentiating group 1 pulmonary arterial hypertension (PAH) from group 2 pulmonary hypertension associated with left heart disease. Despite the discrepancy between the mPAWP upper physiologic normal and current PAH definitions, the implications of the initial mPAWP for PAH clinical trajectory are poorly understood. Objectives: To model longitudinal mPAWP trajectories in PAH over 10 years and examine the clinical and hemodynamic factors associated with trajectory membership. Methods: Adult patients with PAH with two or more right heart catheterizations were identified from a multiinstitution healthcare system in eastern Massachusetts. mPAWP trajectories were constructed via group-based trajectory modeling. Feature selection was performed in least absolute shrinkage and selection operator regression. Logistic regression was used to assess associations between trajectory membership, baseline characteristics, and transplant-free survival. Measurements and Main Results: Among 301 patients with PAH, there were two distinct mPAWP trajectories, termed "mPAWP-high" (n = 71; 23.6%) and "mPAWP-low" (n = 230; 76.4%), based on the ultimate mPAWP value. Initial mPAWP clustered around median 12 mm Hg (interquartile range [IQR], 8-14 mm Hg) in the mPAWP-high and 9 mm Hg (IQR, 6-11 mm Hg) in the mPAWP-low trajectories (P < 0.001). After feature selection, initial mPAWP ⩾12 mm Hg predicted an mPAWP-high trajectory (odds ratio, 3.2; 95% confidence interval, 1.4-6.1; P = 0.0006). An mPAWP-high trajectory was associated with shorter transplant-free survival (vs. mPAWP-low, median, 7.8 vs. 11.3 yr; log-rank P = 0.017; age-adjusted P = 0.217). Conclusions: Over 10 years, the mPAWP followed two distinct trajectories, with 25% evolving into group 2 pulmonary hypertension physiology. Using routine baseline data, longitudinal mPAWP trajectory could be predicted accurately, with initial mPAWP ⩾12 mm Hg as one of the strongest predictors.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Harder EM, Divo MJ, Washko GR, et al. Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2024. PMID: 37939220. doi:10.1164/rccm.202306-1072OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。